Max Healthcare shareholders approve ₹2 dividend, Haryana office shift
Max Healthcare Institute Limited held its 25th AGM on July 30, 2026, where shareholders approved a final dividend of ₹2 per share and the relocation of the registered office to Haryana. The meeting also saw the re-appointment of Anil Kumar Bhatnagar and ratification of auditor fees, with all resolutions passing with significant majority support.

*this image is generated using AI for illustrative purposes only.
Max Healthcare Institute shareholders approved a final dividend of ₹2 per equity share and authorized the relocation of the company’s registered office from Maharashtra to Haryana during its 25th Annual General Meeting (AGM) held on July 30, 2026. The meeting, conducted via video conference, also saw the re-appointment of Anil Kumar Bhatnagar as a director and the ratification of auditor remuneration. The resolutions were passed with overwhelming support, reflecting strong shareholder confidence in the company’s strategic direction and governance framework.
The AGM was chaired by Abhay Soi, Chairman and Managing Director, who highlighted operational progress in FY26, including capacity expansions in Mohali, Mumbai, and Delhi. He noted the recent acquisition of a 58.28% stake in Kalinga Hospital Limited, now Max Super Speciality Hospital, Bhubaneswar, which strengthens the company’s presence in eastern India. Soi emphasized strategic investments in robotic-assisted surgery, AI-driven clinical workflows, and renewable energy infrastructure as key drivers of long-term value creation.
Voting Results Summary
Shareholders transacted both ordinary and special business items. The following table summarizes the voting outcomes for key resolutions:
| Resolution Description | Type | Votes in Favor (%) | Votes Against (%) |
|---|---|---|---|
| Adoption of Audited Standalone Financial Statements for FY26 | Ordinary | 99.9997% | 0.0003% |
| Adoption of Audited Consolidated Financial Statements for FY26 | Ordinary | 99.9997% | 0.0003% |
| Declaration of Final Dividend of ₹2 per equity share | Ordinary | 99.9997% | 0.0003% |
| Re-appointment of Anil Kumar Bhatnagar by rotation | Special | 97.7254% | 2.2746% |
| Approval of remuneration for Non-Executive Directors | Ordinary | 99.9076% | 0.0924% |
| Re-appointment of Anil Kumar Bhatnagar as Non-Executive Director | Special | 97.3803% | 2.6197% |
| Shifting registered office from Maharashtra to Haryana | Special | 99.9991% | 0.0009% |
| Ratification of Cost Auditor remuneration for FY27 | Ordinary | 99.9997% | 0.0003% |
Governance and Compliance
Dhiraj Aroraa, Executive Vice President - Company Secretary and Compliance Officer, confirmed that the company complied with all statutory provisions during FY26. He stated that there were no qualifications or adverse remarks in the Statutory Auditor’s Report issued by S.R. Batliboi & Co. LLP or the Secretarial Auditor’s Report issued by DPV & Associates LLP. Chandra Wadhwa & Co. served as the Cost Auditors.
A quorum of 160 members was present via video conference. The Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee chairs attended to address shareholder queries. Voting was conducted through MUFG Intime India Private Limited using remote e-voting and InstaVote platforms, with Devesh Kumar Vasisht of DPV & Associates LLP acting as Scrutinizer. The cut-off date for voting eligibility was July 23, 2026, with a total of 234,355 shareholders on record.
What the Numbers Show
The declaration of a ₹2 final dividend per equity share, representing 20% of the face value, signals continued cash generation despite significant capital expenditure on hospital expansions and acquisitions. The simultaneous approval of the registered office shift to Haryana suggests a strategic alignment with the company’s operational headquarters in New Delhi, potentially streamlining corporate governance and administrative efficiency. The high approval rates for director re-appointments, despite some dissent from institutional investors, indicate overall trust in the board’s leadership.
Historical Stock Returns for Max Healthcare Institute
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.21% | +4.05% | -2.18% | +18.08% | -11.73% | +307.24% |
How will the relocation of the registered office to Haryana impact Max Healthcare's tax liabilities and regulatory compliance costs in the long term?
What is the expected timeline for the full integration of the acquired Kalinga Hospital into Max Healthcare's eastern India network, and how will this affect regional market share?
Given the significant capital expenditure on robotic surgery and AI workflows, what is the projected ROI timeline for these technology investments?


































